Company intelligence / Profile preview

Spiro Medical

Ownership: Private
Employees: ~15
Development stage: Other

Overview

Spiro Medical has developed the Spiro device, a minimally invasive surgical implant that has received CE Mark approval for the treatment of obstructive sleep apnea (OSA). Clinical evaluations have demonstrated that the implant stabilizes the soft palate to prevent airway collapse during sleep, significantly reducing the Apnea-Hypopnea Index (AHI) in patients with mild to moderate OSA.

Therapeutic areas: Pulmonology
Modalities: Device
Industry: Implantable Medical Devices

Partnerships

Signifier Medical Technologies

Beyond the preview

Go deeper on Spiro Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Spiro Medical.

Explore the full profile